According to the statistics of the my country Hospital Management Association at the end of 2008, the annual prevalence rate of 10,000 people in mainland China was 52.9%, of which 89.5% of the patients received a total of 102,863 chronic dialysis patients, with a prevalence rate of 79.1/100 receiving hemodialysis treatment. The report of the 9th China Blood Purification Forum on August 4, 2017 shows that there are currently more than 120 million patients with chronic kidney disease in my country, of which about 18 million (accounting for 0.13%) have stage 3 or more. In order to avoid adverse reactions of unqualified water quality to patients, dialysis water must be strictly controlled. Otherwise, once bacteria or chemical substances enter the human body, it will cause complications, and the hygienic quality of dialysis water is related to the health and quality of life of many patients with renal failure. In the third summit forum of the blood purification engineering technology alliance of the five southern provinces in 2020, our company and the participating experts discussed, communicated and cooperated, and committed to the continuous improvement of the quality control level in the field of blood purification. For example, our company’s BIOENDO dynamic turbidimetric lysate reagent and dialysis-related endotoxin detection kits and other products, by regularly detecting the endotoxin content of the dialysis system and dialysis-related water, can effectively prevent the dialysis process due to excessive endotoxin content in the system itself. Inflammation in patients can improve the safety of dialysis. Therefore, the content of endotoxin affects the quality and safety of dialysis to a certain extent.
Post time: Mar-15-2021
